Latest Breaking News On - Ramm pharma holdings corp - Page 1 : vimarsana.com
RAMM Pharma Receives Federal Pharmaceutical Approval and Registration of NettaVet™ 10% CBD Formulation, a First for Veterinary Medicine
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
RAMM Pharma Receives Federal Pharmaceutical Approval and Registration of NettaVet™ 10% CBD
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
RAMM Pharma Commences Sales of NettaPet™ CBD Enriched Super Premium Quality Dog Food with .
RAMM Pharma Corp.April 9, 2021 GMT
TORONTO, April 09, 2021 (GLOBE NEWSWIRE) RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM) (OTC: RAMMF), a leader in plant-derived cannabinoid pharmaceutical products, is pleased to announce that it has commenced commercial sales of its NettaPet™ cannabidiol (“CBD”) enriched super premium quality dog food. NettaPet is the first product to be commercialized by RAMM’s wholly owned subsidiary NettaLife which focuses on the production, commercialization and export of CBD enriched pet food, specialty pharmaceutical, cosmetic and other products for animals, as well as research & development in support of total animal wellbeing. Additional information can be found on NettaLife’s website www.nettalife.c
RAMM Pharma Selected as COVID-19 Vaccine Fulfilment & Distribution Partner by the Uruguayan Ministry of Health
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
About the European Cannabis Market
Europe represents one of the largest potential cannabis markets globally. The Europe cannabis market is currently valued at US$3.5 billion and expected to reach US$37 billion by 2027 with an anticipated CAGR of 29.6% from 2020 to 2027 (ResearchAndMarkets.com, 2020). European countries are experiencing a transformation in the regulations for marketing cannabis and related products, facilitating easier cultivation, processing, and trade of the cannabis-derived products across this region.
Terms of the Transaction
The Canapar Shares were acquired for C$7,000,000 pursuant to the terms of a share purchase agreement (the Agreement ) and represent approximately 49% of the issued and outstanding shares of Canapar on a non-diluted basis. Canopy Rivers is also entitled to additional contingent consideration of C$2,000,000 payable in cash or issuable in common shares of RAMM, at the sole discretion of RAMM, on the achievement of certain production mileston